NCELNewcelX Ltd. Ordinary Shares
3.263USDMkt Cap: 18.70M $P/E: —3d ago
NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap18.70M $
Enterprise Value15.53M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-8.30M $
Revenue/Share—
Last Price3.263 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees9
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.62
PEG—
EV/EBITDA-6.20
EV/Revenue—
P/S—
P/B2.23
EPS (TTM)-2.25
EPS (Forward)-0.60
52W Range
3.21553% of range3.305
52W High3.305 USD
52W Low3.215 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-114.48%
ROA-72.52%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.77M $
CapEx (TTM)8.00K $
FCF Margin—
FCF Yield-14.59%
Net Debt-1.85M $
Net Debt/EBITDA0.74
Balance Sheet
Debt/Equity0.05
Current Ratio0.76
Quick Ratio0.58
Book Value/Sh1.510 USD
Cash/Share0.4120 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateOct 31, 2025
Analyst Consensus
Rating—
Target (Mean)23.00 USD
Upside (mean)+604.9%
Target Range23.00 USD – 23.00 USD
# Analysts1
Ownership
Shares Out.5.73M
Float2.61M
Insiders68.06%
Institutions1.35%
Short Interest
Short Ratio1.2d
Short % Float1.33%
Short % Out.0.73%
Shares Short39.22K
Short (prev mo.)56.02K
Technical
SMA 503.581 (-8.9%)
SMA 2003.169 (+2.9%)
Beta—
S&P 52W Chg21.00%
Avg Vol (30d)1.39K
Avg Vol (10d)14.21K
Technical Indicators
RSI (14)43.9
MACD-0.0927
MACD Signal-0.0892
MACD Hist.-0.0035
BB Upper3.634 USD
BB Middle3.389 USD
BB Lower3.144 USD
BB Width14.45%
ATR (14)0.2744 USD
Vol Ratio (20d)0.12x